Literature DB >> 2193644

Antigens of Toxoplasma gondii recognized by sera of AIDS patients before, during, and after clinically important infections.

A Hassl1, H Aspöck.   

Abstract

A longitudinal study of different parameters of the immune responses to Toxoplasma gondii was performed with sera of AIDS patients taken during and after clinically important Toxoplasma infections. Follow-up of patients lasted for 9 months on an average. The titres of the specific IgG and IgM antibodies were measured by an indirect fluorescent antibody test (IFAT), and the appearance of circulating antigens of Toxoplasma gondii was determined in 88 sera of 18 patients with CNS (6 cases), pulmonary (1), lymph-node toxoplasmosis (1), or asymptomatic primary infections (2), respectively. The profile of the IgG antibodies reacting with a lytic antigen originating from a pool of trophozoites of six different Toxoplasma strains were examined by means of an SDS-PAGE followed by an immunoblot. Although numerous antigen bands were recognized by the sera of patients with clinically important infections, an antigen pattern characteristic of an acute infection could not be discovered. The majority of these sera, however, recognized bands at 27 and 57 kd; proteins of these molecular weights are components of the circulating antigens. In patients without any indication of a Toxoplasma infection, small amounts of antibodies reacting with 34-38 kd antigens were detected. The results of this study demonstrate that seropositivity to Toxoplasma gondii in AIDS patients determined by routine serological methods (e.g. IFAT) may be very heterogeneous even if identical titres are found; it simply results from different combinations of various antibodies which can only be detected by the immunoblotting technique.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2193644     DOI: 10.1016/s0934-8840(11)80053-8

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  4 in total

1.  An identical epitope in Pneumocystis carinii and Toxoplasma gondii causing serological cross reactions.

Authors:  A Hassl; W A Müller; H Aspöck
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

2.  Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice.

Authors:  Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Kamal El Bissati; Ying Zhou; Yasuhiro Suzuki; Daniel Lee; Stuart Woods; Caroline Sommerville; Fiona L Henriquez; Craig W Roberts; Rima McLeod
Journal:  Hum Immunol       Date:  2011-10-12       Impact factor: 2.850

3.  Improved diagnosis of reactivated toxoplasmosis.

Authors:  D Ashburn; M M Davidson; A W Joss; T H Pennington; D O Ho-Yen
Journal:  Mol Pathol       Date:  1998-04

4.  Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients.

Authors:  J M Pinon; F Foudrinier; G Mougeot; C Marx; D Aubert; O Toupance; G Niel; M Danis; P Camerlynck; G Remy
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.